The protection of resveratrol and its combination with glibenclamide, but not berberine on the diabetic hearts against reperfusion-induced arrhythmias: the role of myocardial KATP channel

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Archives of Physiology and Biochemistry

• Publication date

  2019-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/13813455.2018.1440409PMID 29457517
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and prevention of cardiovascular disease and diabetes mellitus.

  2016cited by this paper
• Chronic resveratrol treatment improves cardiac function in a rat model of diabetic cardiomyopathy via attenuation of mitochondrial injury and myocardial apoptosis

  2016cited by this paper
• Resveratrol and Cardiovascular Diseases

  2016cited by this paper
• Antiarrhythmic activity of a new spiro-cyclic benzopyran activator of the cardiac mitochondrial ATP dependent potassium channels

  2016cited by this paper
• Berberis Vulgaris and Berberine: An Update Review

  2016cited by this paper
• Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis

  2016cited by this paper
• Berberine Pretreatment Confers Cardioprotection Against Ischemia–Reperfusion Injury in a Rat Model of Type 2 Diabetes

  2016cited by this paper
• Resveratrol attenuates high glucose-induced oxidative stress and cardiomyocyte apoptosis through AMPK.

  2015cited by this paper
• Application of Berberine on Treating Type 2 Diabetes Mellitus

  2015cited by this paper
• The Effect of Cannabidiol on Ischemia/Reperfusion-Induced Ventricular Arrhythmias

  2015cited by this paper
• Kir6.2-containing ATP-sensitive K+ channel is required for cardioprotection of resveratrol in mice

  2014cited by this paper
• Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease

  2014cited by this paper
• Learning from berberine: Treating chronic diseases through multiple targets

  2014cited by this paper
• Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats.

  2014cited by this paper
• Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice

  2014cited by this paper
• Effect of ATP-dependent channel modulators on ischemia-induced arrhythmia change depending on age and gender

  2013cited by this paper
• Berberine Ameliorates Cold and Mechanical Allodynia in a Rat Model of Diabetic Neuropathy

  2013cited by this paper
• Diabetic Cardiovascular Disease: Getting to the Heart of the Matter

  2012cited by this paper
• Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats

  2012cited by this paper
• Increase of ATP-sensitive potassium (KATP) channels in the heart of type-1 diabetic rats

  2012cited by this paper
• Healing the diabetic heart: does myocardial preconditioning work?

  2012cited by this paper
• Sarcolemmal KATP channel modulators and cardiac arrhythmias.

  2011cited by this paper
• Exercise-induced expression of cardiac ATP-sensitive potassium channels promotes action potential shortening and energy conservation.

  2011cited by this paper
• Berberine elicits anti‐arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model

  2011cited by this paper
• Glyburide increases risk in patients with diabetes mellitus after emergent percutaneous intervention for myocardial infarction--a nationwide study.

  2011cited by this paper
• Sarcolemmal K ATP Channel Modulators and Cardiac Arrhythmias

  2011cited by this paper
• Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging.

  2010cited by this paper
• Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin.

  2010cited by this paper
• e0411 Effects of sleep apnea syndrome on myocardial ischaemia in patients with coronary heart disease during night

  2010cited by this paper
• Resveratrol addiction: to die or not to die.

  2009cited by this paper
• Differential Structure of Atrial and Ventricular KATP: Atrial KATP Channels Require SUR1

  2008cited by this paper
• Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats.

  2007cited by this paper
• Glibenclamide action on myocardial function and arrhythmia incidence in the healthy and diabetic heart.

  2007cited by this paper
• Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.

  2007cited by this paper
• Diabetes Mellitus Reduces the Antiarrhythmic Effect of Ion Channel Blockers

  2006cited by this paper
• Long-term treatment with glibenclamide increases susceptibility of streptozotocin-induced diabetic rat heart to reperfusion-induced ventricular tachycardia.

  2005cited by this paper
• Kir6.2 is required for adaptation to stress

  2002cited by this paper
• The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.

  2001cited by this paper
• [Effects of glibenclamide on mRNA level of ATP-sensitive potassium channels of heart in normal and streptozotocin-induced diabetic rats].

  2000cited by this paper
• Effects of streptozotocin-induced diabetes on heart rate, blood pressure and cardiac autonomic nervous control.

  1998cited by this paper
• Myocardial ischemia induces differential regulation of KATP channel gene expression in rat hearts.

  1997cited by this paper
• Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.

  1995cited by this paper
• Long‐Term Diabetogenic Effect of Streptozotocin in Rats

  1993cited by this paper
• The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion.

  1988cited by this paper
• Coronary artery ligation, early arrhythmias, and determination of the ischemic area in conscious rats.

  1983cited by this paper

• Prevention and control of cardiac arrhythmic by using therapeutic foods: A review

  2024cites this paper
• Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress

  2023cites this paper
• Pharmacological mechanism of natural drugs and their active ingredients in the treatment of arrhythmia via calcium channel regulation.

  2023cites this paper
• Berberine: a comprehensive Approach to combat human maladies

  2023cites this paper
• The characteristics and molecular targets of antiarrhythmic natural products.

  2023cites this paper
• Antioxidants in Arrhythmia Treatment—Still a Controversy? A Review of Selected Clinical and Laboratory Research

  2022cites this paper
• Cardioprotection stimulated by resveratrol and grape products prevents lethal cardiac arrhythmias in an animal model of ischemia and reperfusion

  2021cites this paper
• The short form of the SUR1 and its functional implications in the damaged brain

  2021cites this paper
• Molecular mechanisms of action of resveratrol in modulation of diabetic and non-diabetic cardiomyopathy.

  2020cites this paper
• ATP-Sensitive Potassium Channels Mediate the Cardioprotective Effect of Panax notoginseng Saponins against Myocardial Ischaemia–Reperfusion Injury and Inflammatory Reaction

  2020cites this paper
• A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs

  2020cites this paper
• The effect of co-administration of berberine, resveratrol, and glibenclamide on xenobiotic metabolizing enzyme activities in diabetic rat liver

  2020cites this paper
• Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation

  2020cites this paper
• ArrhythmoGenoPharmacoTherapy

  2020cites this paper
• The Coming Age of Flavonoids in the Treatment of Diabetic Complications

  2020cites this paper
• Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review

  2019cites this paper
• Streptozotosin Uygulanan İnsan Pankreatik Hücre Soyu (1.1b4) Üzerine Leontice Leontopetalum Ekstratının Antidiyabetik Etkisinin Araştırılması

  2018cites this paper
• Resveratrol protects against early cardiomyopathic changes-induced by Type-1 diabetes through a heme-oxygenase-1 dependent mechanism

  2018cites this paper
• Screening Of Neuroprotective Role Of Hydroethanolic Extract Of Clematis Buchananiana Leaves On Diabetic-Induced Neuropathy

  year unknowncites this paper